These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18442868)

  • 1. Disease management programmes for patients with coronary heart disease--an empirical study of German programmes.
    Gapp O; Schweikert B; Meisinger C; Holle R
    Health Policy; 2008 Dec; 88(2-3):176-85. PubMed ID: 18442868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument.
    Szecsenyi J; Rosemann T; Joos S; Peters-Klimm F; Miksch A
    Diabetes Care; 2008 Jun; 31(6):1150-4. PubMed ID: 18299443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends in type 2 diabetes patients' disease management and outcomes: evidence from two KORA surveys in Germany.
    Schunk M; Schweikert B; Gapp O; Reitmeir P; Meisinger C; Mielck A; Holle R
    Exp Clin Endocrinol Diabetes; 2009 Feb; 117(2):88-94. PubMed ID: 18726868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gender-specific differences in quality of life of patients with type 2 diabetes with or without participating in DMP].
    Miksch A; Hermann K; Trieschmann J; Roelz A; Heiderhoff M; Laux G; Rosemann T; Szecsenyi J
    Gesundheitswesen; 2008 Apr; 70(4):250-5. PubMed ID: 18512199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective enrollment in Disease Management Programs for coronary heart disease in Germany - An analysis based on cross-sectional survey and administrative claims data.
    Röttger J; Blümel M; Busse R
    BMC Health Serv Res; 2017 Apr; 17(1):246. PubMed ID: 28372554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disease management programmes in Germany: first reactions by patients suffering from diabetes].
    Eller M; Satzinger W; Holle R; Meisinger C; Thorand B;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S144-9. PubMed ID: 16032533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a survival benefit within a German primary care-based disease management program?
    Miksch A; Laux G; Ose D; Joos S; Campbell S; Riens B; Szecsenyi J
    Am J Manag Care; 2010 Jan; 16(1):49-54. PubMed ID: 20148605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease management programs in type 2 diabetes: quality of care.
    Berthold HK; Bestehorn KP; Jannowitz C; Krone W; Gouni-Berthold I
    Am J Manag Care; 2011 Jun; 17(6):393-403. PubMed ID: 21756010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective examination of disease management program use by complex cardiac outpatients.
    Gravely S; Reid RD; Oh P; Ross H; Stewart DE; Grace SL;
    Can J Cardiol; 2012; 28(4):490-6. PubMed ID: 22424663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in medical treatment of chronic coronary heart disease patients according to medical specialities.
    Cordero A; Bertomeu-Martínez V; Mazón P; Quiles J; Aznar J; Bueno H
    Cardiovasc Ther; 2009; 27(3):173-80. PubMed ID: 19689616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disease management programs between aspiration and reality. Actually, everything was meant to become much better].
    Bullmann C; Straub C
    Z Arztl Fortbild Qualitatssich; 2006; 100(1):32-5; discussion 36. PubMed ID: 16524227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [General practitioners' opinion and attitude towards DMPs and the change in practice routines to implement the DMP "diabetes mellitus type 2"].
    Miksch A; Trieschmann J; Ose D; Rölz A; Heiderhoff M; Szecsenyi J
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):427-33. PubMed ID: 21843845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure disease management program experience in 4,545 heart failure admissions to a community hospital.
    Pazin-Filho A; Peitz P; Pianta T; Carson KA; Russell SD; Boulware LE; Coresh J
    Am Heart J; 2009 Sep; 158(3):459-66. PubMed ID: 19699871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008-2010.
    Bozorgmehr K; San Sebastian M; Brenner H; Razum O; Maier W; Saum KU; Holleczek B; Miksch A; Szecsenyi J
    Int J Equity Health; 2015 Mar; 14():28. PubMed ID: 25879523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study.
    Buckley B; Murphy AW
    Heart; 2009 Mar; 95(6):461-7. PubMed ID: 18669551
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.